{"article_title": "Prothena Reports Positive Results for Parkinson\u2019s Treatment in Early-Stage Study", "article_keywords": ["reduce", "studythe", "showed", "positive", "study", "disease", "parkinsons", "results", "reports", "system", "roche", "earlystage", "treatment", "known", "prothena", "safely", "stage"], "article_url": "http://www.wsj.com/articles/prothena-reports-positive-results-for-parkinsons-treatment-in-early-stage-study-1426807506", "article_text": "Prothena Corp. said its Parkinson's disease treatment showed the ability to safely reduce a key protein potentially linked to the disease, in an early stage study.\n\nThe treatment, known as PRX002, is one of a new class of drugs known as immunotherapies, which use the body\u2019s immune system to fight diseases. Prothera is joining with Roche to...", "article_metadata": {"article.template": "snippet", "article.created": "2015-03-19T23:25:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Prothena Corp. said its Parkinson's disease treatment showed the ability to reduce safely a key protein potentially linked to the disease, in an early stage study.", "title": "Prothena Reports Positive Results for Parkinson\u2019s Treatment in Early-Stage Study", "image": {"alt": "Prothena reports positive results for Parkinson\u2019s treatment in early-stage study", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB12209092869933114318104580528770295003704&headline=Prothena%20reports%20positive%20results%20for%20Parkinson%u2019s%20treatment%20in%20early-stage%20study&weburl=http://www.wsj.com/articles/SB12209092869933114318104580528770295003704"}}, "page.site.product": "WSJ", "keywords": "gene kinney,monoclonal antibodies,parkinson's,prothena,prx002,roche,Prothena,PRTA,corporate,industrial news,biotechnology,political,general news,health,medical conditions,parkinson's disease,sciences,technologies,pharmaceuticals,health care,life sciences,specialized drugs,medications", "news_keywords": "gene kinney,monoclonal antibodies,parkinson's,prothena,prx002,roche,Prothena,PRTA,corporate,industrial news", "article.headline": "Prothena reports positive results for Parkinson\u2019s treatment in early-stage study", "description": "Prothena Corp. said its Parkinson's disease treatment showed the ability to reduce safely a key protein potentially linked to the disease, in an early stage study.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB12209092869933114318104580528770295003704&headline=Prothena%20reports%20positive%20results%20for%20Parkinson%u2019s%20treatment%20in%20early-stage%20study&weburl=http://www.wsj.com/articles/SB12209092869933114318104580528770295003704", "user.type": "nonsubscriber", "testkeys": "C", "article.page": "Business", "article.summary": "Prothena Corp. said its Parkinson's disease treatment showed the ability to reduce safely a key protein potentially linked to the disease, in an early stage study.", "page.site": "wsj", "page.content.format": "responsive", "article.published": "2015-03-19T23:25:00.000Z", "dj.asn": "i-73e8", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "word_count": 225}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Prothena Corp. said its Parkinson's disease treatment showed the ability to reduce safely a key protein potentially linked to the disease, in an early stage study.", "title": "Prothena Reports Positive Results for Parkinson\u2019s Treatment in Early-Stage Study", "url": "http://www.wsj.com/articles/prothena-reports-positive-results-for-parkinsons-treatment-in-early-stage-study-1426807506", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Lisa Beilfuss", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Prothena Reports Positive Results for Parkinson\u2019s Treatment in Early-Stage Study", "article.type": "Business", "article.id": "SB12209092869933114318104580528770295003704", "user.exp": "default", "article.updated": "2015-03-19T23:25:00.000Z"}, "_id": "\"57477af36914bd0286fcfd13\"", "article_summary": "Prothena Corp. said its Parkinson's disease treatment showed the ability to safely reduce a key protein potentially linked to the disease, in an early stage study.\nThe treatment, known as PRX002, is one of a new class of drugs known as immunotherapies, which use the body\u2019s immune system to fight diseases.\nProthera is joining with Roche to..."}